摘要：This article examines three developing countries to identify capacities for innovative science policy: Brazil, South Africa and the Philippines. Using membership in regional trading agreements, we assess whether these three nations have aligned their science/innovation policy with the partners of their trading agreements. This assessment provides insights into the potential trade-offs that other developing nations will need to consider as they contemplate the adoption of genetically modified crops.
